Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

The ArteraAI Prostate Test uses AI to analyze biopsy images, predicting hormone therapy benefits for prostate cancer patients. Approved in the US and UK, the test aids early diagnostic decisions, ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...

Q. I’m 76 years old, and I’ve taken an aspirin every day since I was 28 because of arthritis. Although cancer runs in my family on both sides, I’ve never had cancer of any sort.My dad died of prostate ...